Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial
Naslov
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial
Identifikator
/unibl/sci/idNaucniRad:36017
/unibl/sci/idNaucniRad:24617
Tip
Pronađite slične unoseAcademic Article
Datum
Pronađite slične unose2018-08
Bibliografski citat
LJ. Božić, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, STED Journal, Aug, 2018
Je dio
STED Journal
2637-2150
Lista autora
Position: 138263 (13 views)